Pharma Official Says Having Employee Buy-In Key to Improving Quality
This article was originally published in The Gold Sheet
Executive Summary
Pharma industry officials say that having strong employee buy-in is a key ingredient to improve manufacturing quality and decrease variability. An official from Eli Lilly offers a case study on how this approach helped them improve the bottom line.
You may also be interested in...
Firms That Get Complete Response Letters Might Get Inspected By US FDA Six Months After Replies
While COVID-19 continues to wreak havoc on FDA's ability to perform onsite preapproval inspections, new guidance offers some clarity, but the news isn't great for ANDA holders.
COVID-19 Spurs WHO To Revise Guidance On Technology Transfers
The WHO proposes to revise 2011 guidance on technology transfers to ease the hand-off of COVID-19 drugs and vaccines from research and development facilities to commercial sites.
Nitrosamine Testing Policy From European Pharmacopeia’ Largely Aligns With USP
Two groups have issued largely complementary testing methods for measuring nitrosamine impurities in drugs, and the differences that do exist are “insignificant,” EDQM official advises. The two are working to further harmonize testing standards, given the global scope of the nitrosamine scare.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: